Endothelial Dysfunction Clinical Trial
— VRPMOfficial title:
Effects of Tomato Sauce on Endothelial Dysfunction Induced by a High Fat Meal in Healthy Subjects
Verified date | April 2019 |
Source | Universita di Verona |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Several epidemiological and intervention studies suggest that a high dietary intake of
tomatoes is associated with lower risk of cardiovascular disease (CVD), while, low intake is
associated with an increased incidence of CVD. This beneficial effects have been attributed
especially to lycopene, an antioxidant present in high concentration within tomatoes but
other substances could be of importance.
Endothelial dysfunction is an early marker of atherosclerosis leading to CVD. The aim of the
present study is therefore to investigate whether consumption of tomato products ameliorates
peripheral endothelial function, triggered by a high fat meal, in human volunteers in a
randomised, crossover dietary intervention study.
Study design:
Investigators are randomising healthy men (N=14-28) to consume a high fat meal either with or
without tomato sauce (80 gr) in a cross-over design with a 7 days wash-out period. During the
week before the study all the subjects will be maintained in a low fibers diet and only
subjects randomized to tomatoes will receive a daily dose of 80 mg of tomato sauce (80 gr for
7 days= total load 560 mg).
We hypothesize that tomato sauce can improve the deleterious effects of a high fat meal on
vascular function.
Status | Completed |
Enrollment | 19 |
Est. completion date | December 2015 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 38 Years |
Eligibility |
Inclusion Criteria: - Healthy men, - without overt risk factors for CVD (see exclusion criteria); - age range 28 ±10 years; - BMI between 19-27 Kg/m2 Exclusion Criteria: - Previous cardiovascular events, kidney failure (serum creatinine =1,5 mg/dl), arterial blood pressure =140/90mmHg or diagnosed hypertension; chronic inflammatory or neoplastic diseases, diabetes mellitus or impaired fasting glucose (glucose =110 mg/dL), hypercholesterolemia (total cholesterol =240 mg/dl or anti-lipemic medication use), current smoking, antihypertensive medications; use of antioxidant drugs or NSAIDs or COXIBs; food allergy to tomato or other components of the high fat diet. |
Country | Name | City | State |
---|---|---|---|
Italy | University of Verona | Verona |
Lead Sponsor | Collaborator |
---|---|
Universita di Verona |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | plasma level of lycopene and other substances contained in tomatoes. | change 2 and 3.5 hour after a high fat meal | ||
Other | glucose and lipid | glucose and lipid variation | change 2 and 3.5 hour after a high fat meal | |
Primary | Flow Mediated Dilatation (FMD) | Endothelial function as measured non-invasively by ultrasound (LogiQ P5 pro, GE Healthcare) using the "Flow Mediated Dilatation" (FMD) technique with the aid of a dedicated hardware (Multimedia Video Engine II (MVE2) DSP Lab., Pisa CNR, Italy). | change in FMD 2 and 3.5 hour after a high fat meal | |
Secondary | Arterial stiffness measured as Stiffness Index (SI), Carotid distensibility (CD) | systemic and local arterial stiffness measured by digital photoplethysmography (PulseTracePT1000 - MicroMedical Ltd) and by carotid ultrasound (LogiQ P5 pro, GE Healthcare) with the aid of a dedicated hardware (Multimedia Video Engine II (MVE2) DSP Lab., Pisa CNR, Italy). | change in SI and CD 2 and 3.5 hour after a high fat meal | |
Secondary | inflammatory cytokines | chnage in inflammatory cytokines 2 and 3.5 hour after a high fat meal | ||
Secondary | blood pressure | office blood pressure measured by a semiautomatic oscillometric device (TM-2501, A&D instruments Ltd) | change in blood pressure 2 and 3.5 hour after a high fat mealeal |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Completed |
NCT04156711 -
Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery
|
N/A | |
Recruiting |
NCT06133634 -
Fisetin to Improve Vascular Function in Older Adults
|
Phase 1/Phase 2 | |
Completed |
NCT05872139 -
Role of Mitochondrial-derived Oxidative Stress to Promote Vascular Endothelial Dysfunction in Non-exercisers With Aging
|
N/A | |
Recruiting |
NCT04558450 -
Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)
|
N/A | |
Terminated |
NCT03325933 -
Resistance Training and Cardiometabolic Health
|
N/A | |
Not yet recruiting |
NCT05939934 -
Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal
|
N/A | |
Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
Recruiting |
NCT02334839 -
The Association Between Severity of Hypertensive Disorder During Pregnancy and Endothelial Dysfunction
|
N/A | |
Recruiting |
NCT02020044 -
Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
|
N/A | |
Completed |
NCT01691404 -
Study on the Effects of Epicatechin and Quercetin Supplementation on Vascular Function and Blood Pressure (FLAVO)
|
N/A | |
Completed |
NCT01775865 -
Targeting Inflammation to Treat Cardiovascular Aging
|
Phase 2 | |
Terminated |
NCT01412216 -
The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance
|
Phase 2 | |
Completed |
NCT01319344 -
Effect of Eplerenone on Endothelial Function in Metabolic Syndrome
|
Phase 3 | |
Completed |
NCT00848302 -
Endothelial Function in Human Arteries
|
Early Phase 1 | |
Completed |
NCT00990730 -
Atherosclerosis in Rheumatoid Arthritis
|
N/A | |
Completed |
NCT00987974 -
Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury
|
Phase 4 | |
Completed |
NCT00532844 -
A Phase 2, Pharmacokinetic (PK) Study of 6R-BH4 Alone or 6R-BH4 With Vitamin C in Subjects With Endothelial Dysfunction
|
Phase 2 | |
Completed |
NCT00376246 -
Effect of Ezetimibe on Flow-mediated Brachial Artery Reactivity in Healthy Subjects
|
Phase 4 | |
Completed |
NCT00775099 -
Combustion Derived Air Pollution and Vascular Function
|
N/A |